Logo image of NRG.CA

NEWRANGE GOLD CORP (NRG.CA) Stock Fundamental Analysis

Canada - TSX-V:NRG - CA65250B3039 - Common Stock

0.04 CAD
0 (0%)
Last: 10/25/2024, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NRG. NRG was compared to 808 industry peers in the Metals & Mining industry. NRG may be in some trouble as it scores bad on both profitability and health. NRG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NRG was profitable.
In the past year NRG has reported a negative cash flow from operations.
NRG had negative earnings in each of the past 5 years.
NRG had a negative operating cash flow in each of the past 5 years.
NRG.CA Yearly Net Income VS EBIT VS OCF VS FCFNRG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M -4M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -63.82%, NRG is doing worse than 74.21% of the companies in the same industry.
Industry RankSector Rank
ROA -63.82%
ROE N/A
ROIC N/A
ROA(3y)-205.17%
ROA(5y)-150.63%
ROE(3y)-844.43%
ROE(5y)-538.77%
ROIC(3y)N/A
ROIC(5y)N/A
NRG.CA Yearly ROA, ROE, ROICNRG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1.3 Margins

NRG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRG.CA Yearly Profit, Operating, Gross MarginsNRG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, NRG has more shares outstanding
NRG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NRG has an improved debt to assets ratio.
NRG.CA Yearly Shares OutstandingNRG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NRG.CA Yearly Total Debt VS Total AssetsNRG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

2.2 Solvency

NRG has an Altman-Z score of -45.76. This is a bad value and indicates that NRG is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -45.76, NRG is doing worse than 87.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -45.76
ROIC/WACCN/A
WACCN/A
NRG.CA Yearly LT Debt VS Equity VS FCFNRG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 0.46 indicates that NRG may have some problems paying its short term obligations.
NRG has a worse Current ratio (0.46) than 75.43% of its industry peers.
NRG has a Quick Ratio of 0.46. This is a bad value and indicates that NRG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NRG (0.46) is worse than 73.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
NRG.CA Yearly Current Assets VS Current LiabilitesNRG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

NRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4140.82%, which is quite impressive.
EPS 1Y (TTM)4140.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-100.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRG.CA Yearly EPS VS EstimatesNRG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.01 indicates a rather cheap valuation of NRG.
Compared to the rest of the industry, the Price/Earnings ratio of NRG indicates a rather cheap valuation: NRG is cheaper than 100.00% of the companies listed in the same industry.
NRG is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for NRG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 0.01
Fwd PE N/A
NRG.CA Price Earnings VS Forward Price EarningsNRG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRG.CA Per share dataNRG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEWRANGE GOLD CORP

TSX-V:NRG (10/25/2024, 7:00:00 PM)

0.04

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-01 2024-04-01
Earnings (Next)08-21 2024-08-21
Inst Owners0.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.51M
Analysts84.44
Price Target0.2 (400%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)3.96
EY9900%
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-205.17%
ROA(5y)-150.63%
ROE(3y)-844.43%
ROE(5y)-538.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z -45.76
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)945.82%
Cap/Depr(5y)843.9%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4140.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.34%
EPS Next Y-100.78%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y67.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y88.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.97%
OCF growth 3YN/A
OCF growth 5YN/A